Multi-omics reveals changes in astrocyte fatty acid metabolism during early stages of Alzheimer's disease
Neurochemistry International · 2025-11 · 190 · 106049
DOI: 10.1016/j.neuint.2025.106049 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neurochemistry International, 2025-11. Verfasst von Jie Zhong und 3 weiteren Autor:innen. Beteiligte Einrichtung: Shenzhen Key Laboratory for Neuronal Structural Biology, Biomedical Research Institute, Shenzhen - Peking University - the Hong Kong University of Sc…. Hauptthemen laut MEDLINE: Astrocytes, Alzheimer Disease, Fatty Acids. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Shenzhen Technology Development Program, Guangxi Natural Science Foundation, National Natural Science Foundation of China.
Themen: Demenz
Abstract (Originalsprache)
BACKGROUND: Although astrocytes are known to contribute to Alzheimer's disease (AD) progression, their dynamic molecular alterations remain poorly characterized, particularly in early stages of the disease. METHODS: We performed multi-omics profiling (transcriptomics, proteomics, spatial metabolomics) of astrocytes from APP/PS1 and WT mice to characterize dynamic changes during AD progression. To assess similar changes in early human AD, we analyzed single-nucleus RNA sequencing data from human samples. RESULTS: Transcriptomic analysis of astrocytes from APP/PS1 and WT mice at five time points (2, 4, 6, 9, and 12 months of age) showed notable gene expression differences at 6 months, with reduced activity in fatty acid metabolism pathways (e.g., PPAR signaling, biosynthesis of unsaturated fatty acids). An astrocyte-specific metabolic model confirmed these disruptions. Proteomic analysis corroborated this by showing decreased activity in pathways like butanoate metabolism and PPAR signaling. Spatial metabolomics of brain slices from APP/PS1 and WT mice highlighted fatty acid enrichment in the hippocampus and cortex, alongside differential metabolites specific to the AD mouse model. Single-cell RNA sequencing analysis of human brain samples further showed fatty acid metabolism abnormalities in astrocytes from early AD cases versus controls, emphasizing its role in AD progression. CONCLUSION: Our study identified abnormal fatty acid metabolism as an early feature of astrocytes in AD, suggesting an association between dysregulated fatty acid metabolism and disease progression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Shenzhen Key Laboratory for Neuronal Structural Biology, Biomedical Research Institute, Shenzhen - Peking University - the Hong Kong University of Science and Technology Medical Center, Shenzhen, Guangdong Province, Chi…
- Department of Systems Biology, School of Life Sciences, Southern University of Science and Technology, Shenzhen, Guangdong Province, China. Electronic address: daizw@sustech.edu.cn.
Förderung
- Shenzhen Technology Development Program
- Guangxi Natural Science Foundation
- National Natural Science Foundation of China
- National Key Research and Development Program of China
- Guangdong Innovative and Entrepreneurial Research Team Program
- Southern University of Science and Technology
- Defense Health Agency
- Amazon Research Awards
Zitieren
APA
Zhong, J., Li, M., Dai, Z., & Wan, J. (2025). Multi-omics reveals changes in astrocyte fatty acid metabolism during early stages of Alzheimer's disease. Neurochemistry International, 190, 106049. https://doi.org/10.1016/j.neuint.2025.106049
Vancouver
Zhong J, Li M, Dai Z, Wan J. Multi-omics reveals changes in astrocyte fatty acid metabolism during early stages of Alzheimer's disease. Neurochemistry International. 2025;190:106049. doi:10.1016/j.neuint.2025.106049
BibTeX
@article{Zhong2025,
author = {Zhong, Jie and Li, Manhui and Dai, Ziwei and Wan, Jun},
title = {Multi-omics reveals changes in astrocyte fatty acid metabolism during early stages of Alzheimer's disease},
journal = {Neurochemistry International},
year = {2025},
volume = {190},
pages = {106049},
doi = {10.1016/j.neuint.2025.106049}
}
EUVIMED